Inadequate use of asthma medication in the United States: Results of the Asthma in America national population survey

Robert J. Adams, Anne Fuhlbrigge, Theresa Guilbert, Paula Lozano, Fernando Martinez

Research output: Contribution to journalArticle

216 Citations (Scopus)

Abstract

Background: Studies of the use of anti-inflammatory asthma therapy have been limited to selected populations or have been unable to assess the appropriateness of therapy for individuals. Objective: We sought to describe the current use of asthma medication in the United States population and to examine the influence of symptoms and sociodemographics on medication use. Methods: This study was based on a cross-sectional, national, random-digit-dial household telephone survey in 1998 designed to identify adult patients and parents of children with current asthma. Respondents were classified as having current asthma if they had a physician's diagnosis of asthma and were either taking medication for asthma or had asthma symptoms during the past year. Results: One or more persons met the study criteria for current asthma in 3273 (7.8%) households in which a screening questionnaire was completed. Of these, 2509 persons (721 children <16 years) with current asthma were interviewed. Current use of anti-inflammatory medication was reported by 507 (20.1%). Of these, most were using inhaled corticosteroids (72.5%), with use of antileukotrienes reported by 11.4% and use of cromolynnedocromil reported by 18.6%. Of persons with persistent asthma symptoms in the past month, 26.2% reported current use of some form of anti-inflammatory medication. In bivariate analysis persons reporting lower income, less education, and present unemployment, as well as smokers, were significantly (P <.001) less likely to report current anti-inflammatory use than were other populations. In a multiple regression model nonsmokers and those of white, non-Hispanic ethnicity, as well as persons reporting less asthma control, were more likely to report current anti-inflammatory medication use. Conclusion: In the United States use of appropriate asthma therapy remains inadequate. Strategies to increase use of anti-inflammatory therapy among patients with asthma are needed. These might include methods to increase access to asthma care for minorities and the socioeconomically disadvantaged.

Original languageEnglish (US)
Pages (from-to)58-64
Number of pages7
JournalJournal of Allergy and Clinical Immunology
Volume110
Issue number1
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Asthma
Population
Anti-Inflammatory Agents
Surveys and Questionnaires
Unemployment
Vulnerable Populations
Therapeutics
Telephone
Adrenal Cortex Hormones
Parents
Physicians
Education

Keywords

  • Asthma
  • Asthma medication
  • Population survey
  • Race
  • Socioeconomic status

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Inadequate use of asthma medication in the United States : Results of the Asthma in America national population survey. / Adams, Robert J.; Fuhlbrigge, Anne; Guilbert, Theresa; Lozano, Paula; Martinez, Fernando.

In: Journal of Allergy and Clinical Immunology, Vol. 110, No. 1, 2002, p. 58-64.

Research output: Contribution to journalArticle

@article{7f58f246c5614b5c9c4efb057507846a,
title = "Inadequate use of asthma medication in the United States: Results of the Asthma in America national population survey",
abstract = "Background: Studies of the use of anti-inflammatory asthma therapy have been limited to selected populations or have been unable to assess the appropriateness of therapy for individuals. Objective: We sought to describe the current use of asthma medication in the United States population and to examine the influence of symptoms and sociodemographics on medication use. Methods: This study was based on a cross-sectional, national, random-digit-dial household telephone survey in 1998 designed to identify adult patients and parents of children with current asthma. Respondents were classified as having current asthma if they had a physician's diagnosis of asthma and were either taking medication for asthma or had asthma symptoms during the past year. Results: One or more persons met the study criteria for current asthma in 3273 (7.8{\%}) households in which a screening questionnaire was completed. Of these, 2509 persons (721 children <16 years) with current asthma were interviewed. Current use of anti-inflammatory medication was reported by 507 (20.1{\%}). Of these, most were using inhaled corticosteroids (72.5{\%}), with use of antileukotrienes reported by 11.4{\%} and use of cromolynnedocromil reported by 18.6{\%}. Of persons with persistent asthma symptoms in the past month, 26.2{\%} reported current use of some form of anti-inflammatory medication. In bivariate analysis persons reporting lower income, less education, and present unemployment, as well as smokers, were significantly (P <.001) less likely to report current anti-inflammatory use than were other populations. In a multiple regression model nonsmokers and those of white, non-Hispanic ethnicity, as well as persons reporting less asthma control, were more likely to report current anti-inflammatory medication use. Conclusion: In the United States use of appropriate asthma therapy remains inadequate. Strategies to increase use of anti-inflammatory therapy among patients with asthma are needed. These might include methods to increase access to asthma care for minorities and the socioeconomically disadvantaged.",
keywords = "Asthma, Asthma medication, Population survey, Race, Socioeconomic status",
author = "Adams, {Robert J.} and Anne Fuhlbrigge and Theresa Guilbert and Paula Lozano and Fernando Martinez",
year = "2002",
doi = "10.1067/mai.2002.125489",
language = "English (US)",
volume = "110",
pages = "58--64",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Inadequate use of asthma medication in the United States

T2 - Results of the Asthma in America national population survey

AU - Adams, Robert J.

AU - Fuhlbrigge, Anne

AU - Guilbert, Theresa

AU - Lozano, Paula

AU - Martinez, Fernando

PY - 2002

Y1 - 2002

N2 - Background: Studies of the use of anti-inflammatory asthma therapy have been limited to selected populations or have been unable to assess the appropriateness of therapy for individuals. Objective: We sought to describe the current use of asthma medication in the United States population and to examine the influence of symptoms and sociodemographics on medication use. Methods: This study was based on a cross-sectional, national, random-digit-dial household telephone survey in 1998 designed to identify adult patients and parents of children with current asthma. Respondents were classified as having current asthma if they had a physician's diagnosis of asthma and were either taking medication for asthma or had asthma symptoms during the past year. Results: One or more persons met the study criteria for current asthma in 3273 (7.8%) households in which a screening questionnaire was completed. Of these, 2509 persons (721 children <16 years) with current asthma were interviewed. Current use of anti-inflammatory medication was reported by 507 (20.1%). Of these, most were using inhaled corticosteroids (72.5%), with use of antileukotrienes reported by 11.4% and use of cromolynnedocromil reported by 18.6%. Of persons with persistent asthma symptoms in the past month, 26.2% reported current use of some form of anti-inflammatory medication. In bivariate analysis persons reporting lower income, less education, and present unemployment, as well as smokers, were significantly (P <.001) less likely to report current anti-inflammatory use than were other populations. In a multiple regression model nonsmokers and those of white, non-Hispanic ethnicity, as well as persons reporting less asthma control, were more likely to report current anti-inflammatory medication use. Conclusion: In the United States use of appropriate asthma therapy remains inadequate. Strategies to increase use of anti-inflammatory therapy among patients with asthma are needed. These might include methods to increase access to asthma care for minorities and the socioeconomically disadvantaged.

AB - Background: Studies of the use of anti-inflammatory asthma therapy have been limited to selected populations or have been unable to assess the appropriateness of therapy for individuals. Objective: We sought to describe the current use of asthma medication in the United States population and to examine the influence of symptoms and sociodemographics on medication use. Methods: This study was based on a cross-sectional, national, random-digit-dial household telephone survey in 1998 designed to identify adult patients and parents of children with current asthma. Respondents were classified as having current asthma if they had a physician's diagnosis of asthma and were either taking medication for asthma or had asthma symptoms during the past year. Results: One or more persons met the study criteria for current asthma in 3273 (7.8%) households in which a screening questionnaire was completed. Of these, 2509 persons (721 children <16 years) with current asthma were interviewed. Current use of anti-inflammatory medication was reported by 507 (20.1%). Of these, most were using inhaled corticosteroids (72.5%), with use of antileukotrienes reported by 11.4% and use of cromolynnedocromil reported by 18.6%. Of persons with persistent asthma symptoms in the past month, 26.2% reported current use of some form of anti-inflammatory medication. In bivariate analysis persons reporting lower income, less education, and present unemployment, as well as smokers, were significantly (P <.001) less likely to report current anti-inflammatory use than were other populations. In a multiple regression model nonsmokers and those of white, non-Hispanic ethnicity, as well as persons reporting less asthma control, were more likely to report current anti-inflammatory medication use. Conclusion: In the United States use of appropriate asthma therapy remains inadequate. Strategies to increase use of anti-inflammatory therapy among patients with asthma are needed. These might include methods to increase access to asthma care for minorities and the socioeconomically disadvantaged.

KW - Asthma

KW - Asthma medication

KW - Population survey

KW - Race

KW - Socioeconomic status

UR - http://www.scopus.com/inward/record.url?scp=0036966115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036966115&partnerID=8YFLogxK

U2 - 10.1067/mai.2002.125489

DO - 10.1067/mai.2002.125489

M3 - Article

C2 - 12110821

AN - SCOPUS:0036966115

VL - 110

SP - 58

EP - 64

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 1

ER -